PE20200383A1 - Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados - Google Patents
Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificadosInfo
- Publication number
- PE20200383A1 PE20200383A1 PE2019001790A PE2019001790A PE20200383A1 PE 20200383 A1 PE20200383 A1 PE 20200383A1 PE 2019001790 A PE2019001790 A PE 2019001790A PE 2019001790 A PE2019001790 A PE 2019001790A PE 20200383 A1 PE20200383 A1 PE 20200383A1
- Authority
- PE
- Peru
- Prior art keywords
- purified
- terpens
- compositions including
- cannabinoids
- selected compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Referido a una composicion que comprende un primer cannabinoide purificado; y un compuesto elegido de un segundo cannabinoide purificado o un primer terpeno purificado. En donde el primer terpeno purificado se elige entre 7,8-dihidro-alfa-ionona, acetanisol, limoneno, entre otros; el primer cannabinoide purificado se elige entre acido cannabigerolico (CBGA), cannabigerol (CBG), tetrahidrocannabinol (THC), entre otros. En donde dicha composicion tiene una pureza superior al 80 % y su formulacion comprende combinaciones intencionalmente disenadas de proporciones y concentraciones no naturales.
Applications Claiming Priority (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465688P | 2017-03-01 | 2017-03-01 | |
US201762469415P | 2017-03-09 | 2017-03-09 | |
US201762475153P | 2017-03-22 | 2017-03-22 | |
US201762477990P | 2017-03-28 | 2017-03-28 | |
US201762489360P | 2017-04-24 | 2017-04-24 | |
US201762490465P | 2017-04-26 | 2017-04-26 | |
US201762490567P | 2017-04-26 | 2017-04-26 | |
US201762491175P | 2017-04-27 | 2017-04-27 | |
US201762491160P | 2017-04-27 | 2017-04-27 | |
US201762491980P | 2017-04-28 | 2017-04-28 | |
US201762491899P | 2017-04-28 | 2017-04-28 | |
US201762509651P | 2017-05-22 | 2017-05-22 | |
US201762510229P | 2017-05-23 | 2017-05-23 | |
US201762510660P | 2017-05-24 | 2017-05-24 | |
US201762510672P | 2017-05-24 | 2017-05-24 | |
US201762511218P | 2017-05-25 | 2017-05-25 | |
US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
PCT/US2018/020440 WO2018160827A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20200383A1 true PE20200383A1 (es) | 2020-02-24 |
Family
ID=63370542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2019001790A PE20200383A1 (es) | 2017-03-01 | 2018-03-01 | Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3589129A4 (es) |
CN (1) | CN110582206A (es) |
AU (1) | AU2018227544A1 (es) |
BR (1) | BR112019018088A2 (es) |
CA (1) | CA3054690A1 (es) |
CO (1) | CO2019009413A2 (es) |
IL (1) | IL268929A (es) |
MX (1) | MX2019010370A (es) |
PE (1) | PE20200383A1 (es) |
WO (1) | WO2018160827A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10737198B2 (en) | 2018-01-23 | 2020-08-11 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
WO2021012044A1 (en) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
KR20220106158A (ko) * | 2019-11-26 | 2022-07-28 | 라이코드 리미티드 | 칸나비노이드 및 라이코펜 항염증 상승작용적 조합물 |
EP4142929A4 (en) * | 2020-04-29 | 2024-02-21 | Ligar Lp | IMPRESSION POLYMERS AND METHODS FOR THEIR USE |
CA3152633A1 (en) * | 2020-07-27 | 2022-02-03 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
WO2022165165A1 (en) * | 2021-01-29 | 2022-08-04 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
WO2023245185A1 (en) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprising cannabinoids and methods of preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
CA2931039C (en) * | 2013-11-20 | 2022-07-12 | Mary Lynch | Compositions and methods for treatment of ocular inflammation and pain |
BR112017018316A2 (pt) * | 2015-02-27 | 2018-04-17 | Ebbu Llc | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral |
-
2018
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/en not_active Withdrawn
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 CA CA3054690A patent/CA3054690A1/en active Pending
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/en unknown
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL268929A (en) | 2019-10-31 |
MX2019010370A (es) | 2019-10-22 |
EP3589129A4 (en) | 2020-11-25 |
AU2018227544A1 (en) | 2019-08-29 |
CN110582206A (zh) | 2019-12-17 |
CA3054690A1 (en) | 2018-09-07 |
WO2018160827A1 (en) | 2018-09-07 |
BR112019018088A2 (pt) | 2020-03-24 |
CO2019009413A2 (es) | 2019-09-09 |
EP3589129A1 (en) | 2020-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20200383A1 (es) | Composiciones intencionalmente seleccionadas que comprenden cannabinoides purificados y/o terpenos purificados | |
PE20190318A1 (es) | Composicion administrable oralmente | |
CL2017002335A1 (es) | Composiciones de cosmetica topica para combatir radicales libres | |
SV1999000072A (es) | Composiciones estabilizadas | |
ES2721148T3 (es) | Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso | |
CL2017001983A1 (es) | Composiciones farmacéuticas para terapia combinada. | |
CL2008000959A1 (es) | Compuestos derivados de 1,2,4-tiadiazina o 1,4-tiazina; composiciones farmaceuticas que los contienen; y su uso para la prevencion y/o tratamiento de infecciones producidas por el virus de la hepatitis c. | |
BR112014029754B1 (pt) | soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição | |
CR11316A (es) | Derivado de uracilo o timina para el tratamiiento de la hepatitis c. | |
WO2008036653A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
ECSP034830A (es) | Derivados sustituidos de la ciclohexano-1,4- diamina | |
BR112017015032A2 (pt) | composições curáveis e membranas | |
RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
BR112019024785A2 (pt) | composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso | |
RU2011138101A (ru) | Фармацевтическая композиция, проявляющая противовоспалительные свойства | |
ECSP11010755A (es) | Povidona yodada, una nueva alternativa conservante para composiciones oftálmicas | |
BR112019000911A2 (pt) | composições de ácido sintético de cloridrato de lisina, como alternativas aos ácidos convencionais na indústria de petróleo e gás | |
BRPI0410660A (pt) | derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2 | |
NO20062696L (no) | Molluskisid og anti-gro forbindelser | |
CO6231001A2 (es) | Estabilizacion de vitamina b12 | |
DE602006017724D1 (de) | Salicylsäurederivate | |
WO2012071389A3 (en) | Stable cannabinoid compositions and methods for making and storing them | |
AR059927A1 (es) | Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas | |
BR112018012952A2 (pt) | composições para higiene pessoal | |
AR061093A1 (es) | Composiciones de calcio |